{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:49:32Z","timestamp":1762285772540,"version":"build-2065373602"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.exphem.2025.104801","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T02:31:54Z","timestamp":1746844314000},"page":"104801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-8124","authenticated-orcid":false,"given":"Bardia","family":"Samareh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Klimenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Aghaallaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Zikic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houra","family":"Loghmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Tesakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0702-6209","authenticated-orcid":false,"given":"Patrick","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-8838","authenticated-orcid":false,"given":"Meinolf","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Skokowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3876-3217","authenticated-orcid":false,"given":"Tatsuya","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.104801_bib0001","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41375-018-0179-9","article-title":"Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial","volume":"32","author":"Suttorp","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104801_bib0002","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3324\/haematol.2017.170035","article-title":"Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents","volume":"102","author":"Millot","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104801_bib0003","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2016.115","article-title":"The concept of treatment-free remission in chronic myeloid leukemia","volume":"30","author":"Saussele","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104801_bib0004","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","volume":"129","author":"Holyoake","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrclinonc.2015.193","article-title":"Allogeneic transplantation for CML in the TKI era: striking the right balance","volume":"13","author":"Innes","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.exphem.2025.104801_bib0006","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/asheducation-2017.1.102","article-title":"Treatment-free remission in CML: who, how, and why?","volume":"2017","author":"Mahon","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.exphem.2025.104801_bib0007","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1200\/JCO.2010.32.7114","article-title":"Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial","volume":"29","author":"Millot","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2025.104801_bib0008","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpeds.2011.03.046","article-title":"Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia","volume":"159","author":"Shima","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.exphem.2025.104801_bib0009","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.23389","article-title":"Imatinib has adverse effect on growth in children with chronic myeloid leukemia","volume":"59","author":"Bansal","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.exphem.2025.104801_bib0010","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.ejca.2014.10.007","article-title":"Growth deceleration in children treated with imatinib for chronic myeloid leukaemia","volume":"50","author":"Millot","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2025.104801_bib0011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2015-06-648667","article-title":"Pediatric chronic myeloid leukemia is a unique disease that requires a different approach","volume":"127","author":"Hijiya","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0012","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00277-013-1937-4","article-title":"Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV","volume":"93","author":"Kalmanti","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2025.104801_bib0013","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/gcc.21989","article-title":"Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia","volume":"51","author":"Krumbholz","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2025.104801_bib0014","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1158\/1078-0432.CCR-14-0624","article-title":"On-target effect of FK866, a nicotinamide phosphoribosyl transferase inhibitor, by apoptosis-mediated death in chronic lymphocytic leukemia cells","volume":"20","author":"Gehrke","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2025.104801_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nm.1913","article-title":"NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway","volume":"15","author":"Skokowa","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2025.104801_bib0016","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ijc.27726","article-title":"Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells","volume":"132","author":"Thakur","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2025.104801_bib0017","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L","article-title":"Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis","volume":"32","author":"Rongvaux","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2025.104801_bib0018","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3324\/haematol.2011.055236","article-title":"The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells","volume":"97","author":"Dan","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.104801_bib0019","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104801_bib0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.104801_bib0021","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","article-title":"Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain","volume":"90","author":"Gu","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104801_bib0022","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","article-title":"Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia","volume":"25","author":"Quintas-Cardama","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104801_bib0023","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbrc.2012.06.084","article-title":"Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway","volume":"424","author":"Thakur","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2025.104801_bib0024","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.2019000095","article-title":"LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis","volume":"134","author":"Morishima","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0025","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/eji.201242413","article-title":"Deacetylation of C\/EBPbeta is required for IL-4-induced arginase-1 expression in murine macrophages","volume":"42","author":"Serrat","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2025.104801_bib0026","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/emboj\/cdg094","article-title":"STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C\/EBPbeta","volume":"22","author":"Xu","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2025.104801_bib0027","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1182\/blood-2013-12-543850","article-title":"Acetylation of C\/EBPepsilon is a prerequisite for terminal neutrophil differentiation","volume":"125","author":"Bartels","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0028","first-page":"7436","article-title":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis","volume":"63","author":"Hasmann","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2025.104801_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10637-007-9083-2","article-title":"The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor","volume":"26","author":"Holen","year":"2008","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.exphem.2025.104801_bib0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamadermatol.2016.0401","article-title":"Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma: a phase 2 clinical trial","volume":"152","author":"Goldinger","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.exphem.2025.104801_bib0031","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00280-009-1125-3","article-title":"Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data","volume":"65","author":"von Heideman","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.exphem.2025.104801_bib0032","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/toxsci\/kfu268","article-title":"Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase","volume":"144","author":"Zabka","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.exphem.2025.104801_bib0033","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ng1940","article-title":"HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)","volume":"39","author":"Klein","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.104801_bib0034","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/nm.2958","article-title":"Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis","volume":"18","author":"Skokowa","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2025.104801_bib0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.hoc.2012.11.001","article-title":"Defective G-CSFR signaling pathways in congenital neutropenia","volume":"27","author":"Skokowa","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.exphem.2025.104801_bib0036","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.leukres.2012.01.017","article-title":"High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients","volume":"36","author":"Butrym","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2025.104801_bib0037","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI24276","article-title":"HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses","volume":"115","author":"Scielzo","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2025.104801_bib0038","first-page":"9367","article-title":"Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage","volume":"17","author":"Kitamura","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2025.104801_bib0039","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1073\/pnas.90.8.3631","article-title":"Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling","volume":"90","author":"Yamanashi","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.exphem.2025.104801_bib0040","doi-asserted-by":"crossref","first-page":"37988","DOI":"10.1074\/jbc.M504552200","article-title":"The coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2\/3 complex","volume":"280","author":"Hao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.104801_bib0041","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte\u2013macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2025.104801_bib0042","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","article-title":"Genetic and pharmacologic inhibition of beta-catenin targets imatinib-resistant leukemia stem cells in CML","volume":"10","author":"Heidel","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2025.104801_bib0043","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.104801_bib0044","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V74.4.1381.1381","article-title":"CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia","volume":"74","author":"Kuriyama","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0045","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0046","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V95.6.2118","article-title":"STAT5 activation contributes to growth and viability in Bcr\/Abl-transformed cells","volume":"95","author":"Sillaber","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0047","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members","volume":"271","author":"Jr","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.104801_bib0048","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nchembio.775","article-title":"BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia","volume":"8","author":"Hantschel","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2025.104801_bib0049","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2006.06161.x","article-title":"BCR-ABL activates STAT3 via JAK and MEK pathways in human cells","volume":"134","author":"Coppo","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2025.104801_bib0050","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1165\/rcmb.2014-0117OC","article-title":"The NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome-associated genetic variants","volume":"51","author":"Sun","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.exphem.2025.104801_bib0051","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1101\/gad.305854.117","article-title":"Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype","volume":"32","author":"Ohanna","year":"2018","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2025.104801_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022739","article-title":"Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells","volume":"6","author":"Cea","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.exphem.2025.104801_bib0053","doi-asserted-by":"crossref","first-page":"25466","DOI":"10.1074\/jbc.M112.364562","article-title":"The actin regulatory protein HS1 interacts with Arp2\/3 and mediates efficient neutrophil chemotaxis","volume":"287","author":"Cavnar","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.104801_bib0054","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.immuni.2006.03.022","article-title":"HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse","volume":"24","author":"Gomez","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2025.104801_bib0055","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.4049\/jimmunol.0900973","article-title":"Hematopoietic lineage cell-specific protein 1 is recruited to the immunological synapse by IL-2-inducible T cell kinase and regulates phospholipase Cgamma1 microcluster dynamics during T cell spreading","volume":"183","author":"Carrizosa","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2025.104801_bib0056","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1074\/jbc.275.11.7887","article-title":"HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells","volume":"275","author":"Ingley","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.104801_bib0057","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1242\/jcs.000786","article-title":"T-cell-receptor-dependent actin regulatory mechanisms","volume":"120","author":"Huang","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2025.104801_bib0058","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.158.6.2736","article-title":"HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases","volume":"158","author":"Suzuki","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2025.104801_bib0059","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2007.09.003","article-title":"Nampt\/PBEF\/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme","volume":"6","author":"Revollo","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.exphem.2025.104801_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","article-title":"NAD+ metabolism in health and disease","volume":"32","author":"Belenky","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.exphem.2025.104801_bib0061","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.RES.0000173298.38808.27","article-title":"Pre\u2013B-cell colony\u2013enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation","volume":"97","author":"van der Veer","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.exphem.2025.104801_bib0062","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","article-title":"Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein","volume":"107","author":"Jaras","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2025.104801_bib0063","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejca.2020.06.024","article-title":"Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: a report from the I-CML-Ped study","volume":"137","author":"Meyran","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2025.104801_bib0064","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/cbt.10.2.12581","article-title":"Nampt\/PBEF\/visfatin and cancer","volume":"10","author":"Bi","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.exphem.2025.104801_bib0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0955-0674(99)80031-3","article-title":"Regulation of LEF-1\/TCF transcription factors by Wnt and other signals","volume":"11","author":"Eastman","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.exphem.2025.104801_bib0066","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells","volume":"15","author":"Gattinoni","year":"2009","journal-title":"Nat Med"},{"issue":"Suppl","key":"10.1016\/j.exphem.2025.104801_bib0067","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0092-8674(02)00709-2","article-title":"WNT signaling and lymphocyte development","volume":"109","author":"van de Wetering","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2025.104801_bib0068","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2015-11-679985","article-title":"IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models","volume":"128","author":"Agerstam","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0069","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/leu.2015.135","article-title":"IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome","volume":"30","author":"Landberg","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104801_bib0070","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104801_bib0071","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.4049\/jimmunol.1100870","article-title":"The actin regulatory protein HS1 is required for antigen uptake and presentation by dendritic cells","volume":"187","author":"Huang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2025.104801_bib0072","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537100802351057","article-title":"Hematopoietic lineage cell-specific protein-1 (HS1) regulates PAR-mediated ERK activation and thromboxane generation in platelets","volume":"19","author":"Kahner","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.exphem.2025.104801_bib0073","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.185.7.1387","article-title":"Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis","volume":"185","author":"Yamanashi","year":"1997","journal-title":"J Exp Med"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X2500092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X2500092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:46:29Z","timestamp":1762285589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X2500092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":73,"alternative-id":["S0301472X2500092X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104801","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104801"}}